Status:
UNKNOWN
Hookworm Immune Regulation Project
Lead Sponsor:
Brugmann University Hospital
Collaborating Sponsors:
Université Libre de Bruxelles
Conditions:
Hookworm Infection
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The main objective of this study is to characterize the regulatory immune response induced by hookworm in an infected Vietnamese rural population from the periphery of HCM, evolution after infection t...
Detailed Description
Population: 20 healthy adults (18-65 years) infected and non infected by Hookworm will be recruited and treated according to Good Clinical Practice recommendations. Allergy will be excluded by skin p...
Eligibility Criteria
Inclusion
- 18-65 years old adults in good health status
- To live in rural regions at risk of soil transmitted helminthes
- Hookworm infection (infected group)
- Uninfected by Hookworms (control group)
Exclusion
- Pregnant woman
- Positive allergic history
- Auto-immune and/or HIV disease
- Antihelminthics drug in the last 6 months and other current parasitic infection
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02262403
Start Date
August 1 2014
End Date
December 1 2021
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pham Ngoc Thach University of Medecine
Ho Chi Minh City, Distict 10, Vietnam